Mannose-binding lectin as a risk factor for acute coronary syndromes

Annals of Medicine

Volumn 41, Issue 8, 2009, Pages 591-598

  Pesonen, Erkki ^a   Hallman, Mikko ^b   Sarna, Seppo ^c   Andsberg, Eva ^a   Haataja, Ritva ^d   Meri, Seppo ^e   Persson, Kenneth ^f   Puolakkainen, Mirja ^e   Öhlin, Hans ^g   Truedsson, Lennart ^g  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

^f Department of Clinical Sciences   (Sweden)

^g LUND UNIVERSITY   (Sweden)

Author keywords

Angina pectoris; Chlamydial heat shock protein 60; Enterovirus; Innate immunity; Mannose binding lectin; Myocardial infarction; Surfactant protein D

Indexed keywords

BACTERIUM ANTIBODY; COMPLEMENT COMPONENT C3; HEAT SHOCK PROTEIN 60; IMMUNOGLOBULIN G; MANNOSE BINDING LECTIN; VIRUS ANTIBODY;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; ANTIBODY TITER; ARTICLE; CARDIOVASCULAR RISK; CHLAMYDOPHILA PNEUMONIAE; COHORT ANALYSIS; COMPLEMENT BLOOD LEVEL; CONTROLLED STUDY; CONVALESCENCE; ENTEROVIRUS; FEMALE; GENOTYPE; HUMAN; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; CHAPERONIN 60; CHLAMYDOPHILA PNEUMONIAE; COHORT STUDIES; COMPLEMENT C3; ENTEROVIRUS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATION; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 72949119387     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.1080/07853890903110994     Document Type: Article

References (37)

1. Lusis AJ, Fogelman AM, Fonarow GC. Genetic basis of atherosclerosis: part I: new genes and pathways. Circulation. 2004;110:1868-1873
2. Futterman LG, Lemberg L. Fifty percent of patients with coronary artery disease do not have any of the conventional risk factors. Am J Crit Care. 1998;7:240.
3. Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290:898-904.
4. Epstein SE, Zhou YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation. 1999;100: 20-28
5. Reunanen A, Roivainen M, Kleemola M, Saikku P, Leinonen M, Hovi T, et al. Enterovirus, mycoplasma and other infections as predictors for myocardial infarction. J Intern Med. 2002;252:421-429
6. Rupprecht H, Blankenberg S, Bickel C. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation. 2001;104:25-31.
7. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G, et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation. 2002;105:15-21. (Pubitemid 34049136)
8. Prasad A, Zhu J, Halcox JP, Waclawiw MA, Epstein SE, Quyyumi AA. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation. 2002;106: 184-190
9. Haagsman HP, Hogenkamp A, van Eijk M, Veldhuizen EJ. Surfactant collectins and innate immunity. Neonatology. 2008;93:288-294
10. Thiel S. Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins. Mol Immunol. 2007;44: 3875-3888
11. Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol. 2005;5:58-68.
12. Sorensen GL, Madsen J, Kejling K, Tornoe I, Nielsen O, Townsend P, et al. Surfactant protein D is proatherogenic in mice. Am J Physiol Heart Circ Physiol. 2006;290:2286-2294
13. Van Till JW, Boermeester MA, Modderman PW, Van Sandick JW, Hart MH, Gisbertz SS, et al. Variable man-nose-binding lectin expression during postoperative acute-phase response. Surg Infect (Larchmt). 2006;7:443-452
14. Rugonfalvi-Kiss S, Endresz V, Madsen HO, Burian K, Duba J, Prohaszka Z, et al. Association of Chlamydia pneumoniae with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin. Circulation. 2002;106:1071-1076
15. Sjoholm AG, Truedsson L, Jensenius JC. Complement pathways and meningococcal disease*diagnostic aspects. In: Pollard AJ, Maiden MCJ, editos. Methods in molecular medicine. Totowa: Humana Press Inc, 2001. p. 529-537
16. Pesonen E, Andsberg E, Ohlin H, Puolakkainen M, Rautelin H, Sarna S, et al. Dual role of infections as risk factors for coronary heart disease. Atherosclerosis. 2007;192:370-375
17. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
18. Madsen HO, Garred P, Thiel S, Kurtzhals JA, Lamm LU, Ryder LP, et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol. 1995;155:3013-3020
19. Carlsson M, Sjoholm AG, Eriksson L, Thiel S, Jensenius JC, Segelmark M, et al. Deficiency of the MBL pathway of complement and poor outcome in cystic fibrosis: bacterial colonization may be decisive for a relationship. Clin Exp Immunol. 2005;139:306-313
20. Leth-Larsen R, Garred P, Jensenius H, Meschi J, Hartshorn K, Madsen J, et al. A common polymorphism in the SFTPD gene influences assembly, function, and concentration of surfactant protein D. J Immunol. 2005;174:1532-1538
21. Engstrom G, Hedblad B, Janzon L, Lindgarde F. Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study. Eur J Cardiovasc Prev Rehabil. 2007;14:392-397
22. Palikhe A, Sinisalo J, Seppanen M, Haario H, Meri S, Valtonen V, et al. Serum complement C3/C4 ratio, a novel marker for recurrent cardiovascular events. Am J Cardiol. 2007;99:890-895
23. Gupta G, Surolia A. Collectins: sentinels of immunity. Bioessays. 2007;29:452-464
24. Holmskov U, Thiel S, Jensenius JC. Collections and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol. 2003;21:547-578
25. Super M, Thiel S, Lu J, Levinsky RJ, Turner MW Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet. 1989;2:1236-1239
26. de Benedetti F, Auriti C, D'Urbano LE, Ronchetti MP, Rava L, Tozzi A, et al. Low serum levels of mannose binding lectin are a risk factor for neonatal sepsis. Pediatr Res. 2007;6:325-328
27. Eisen DP, Dean MM, Boermeester MA, Fidler KJ, Gordon AC, Kronborg G, et al. Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection. Clin Infect Dis. 2008;47:510-516
28. Madsen HO, Videm V, Svejgaard A, Svennevig JL, Garred P. Asscociation of mannose-binding-lectin deficiency with severe atherosclerosis. Lancet. 1998;352:959-960
29. Saevarsdottir S, Oskarsson OO, Aspelund T, Eiriksdottir G, Vikingsdottir T, Gudnason V, et al. Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk. J Exp Med. 2005;201:117-125
30. Ueland T, Espevik T, Kjekshus J, Gullestad L, Omland T, Squire IB, et al. Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction. J Card Fail. 2006;12:659-663
31. Best LG, Davidson M, North KE, MacCluer JW, Zhang Y, Lee ET, et al. Prospective analysis of mannose-binding lectin genotypes and coronary artery disease in American Indians: the Strong Heart Study. Circulation. 2004;109:471-475
32. Hegele RA, Ban MR, Anderson CM, Spence JD. Infection-susceptibility alleles of mannose-binding lectin are associated with increased carotid plaque area. J Investig Med. 2000; 48:198-202.
33. Hansen TK, Tarnow L, Thiel S, Steffensen R, Stehouwer CD, Schalkwijk CG, et al. Association between mannose-binding lectin and vascular complications in type 1 diabetes. Diabetes. 2004;53:1570-1576
34. Rugonfalvi-Kiss S, Dosa E, Madsen HO, Endresz V, Prohaszka Z, Laki J, et al. High rate of early restenosis after carotid eversion endarterectomy in homozygous carriers of the normal mannose-binding lectin genotype. Stroke. 2005; 36:944-948
35. Keller T, van Leuven S, Meuwese M, Wareham N, Luben R, Stroes E, et al. Levels of mannose-binding lectin and the risk of future coronary artery disease in apparently healthy men and women. Arterioscler Thromb Vasc Biol. 2006;26: 2345-2350
36. Jonsen A, Gullstrand B, Güner N, Bengtsson AA, Nived O, Truedsson L, et al. Genetically determined mannan-binding lectin deficiency is of minor importance in determining susceptibility to severe infections and vascular organ damage in systemic lupus erythematosus. Lupus. 2007;16:245-253
37. Troelsen LN, Garred P, Madsen HO, Jacobsen S. Genetically determined high serum levels of mannose-binding lectin and agalactosyl IgG are associated with ischemic heart disease in rheumatoid arthritis. Arthritis Rheum. 2007;56:21-29